News

Results from The Atrial Fibrillation Progression Trial (ATTEST), were presented at the ESC* Congress 2019 in Paris, France. ATTEST is the first randomized controlled trial to directly compare the effectiveness of ablation using radiofrequency...

Medable Inc., the leading provider of digitally enabled and data-driven clinical trials, will join the American Heart Association’s Center for Health Technology & Innovation (the Center) Innovators Network. The Center is focused on...

Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that Informa Pharma Intelligence, a leading international healthcare intelligence consultancy, has recognized...

V-Wave Ltd., a privately held medical device company developing novel implantable interatrial shunt devices, announced that the U.S. Food and Drug Administration (FDA) has just granted the company a Breakthrough Device Designation for its...

Innovative Health, the leading single-use cardiology medical device reprocessing company, announced it has engaged in a formal joint venture with Connecticut-based reprocessor Northeast Scientific. The joint venture aims at enhancing the...

Correvio Pharma Corp., a specialty pharmaceutical company focused on commercializing hospital drugs, announced that an abstract highlighting the results of the SPECTRUM study evaluating Brinavess® (vernakalant hydrochloride, IV), the...

PhysIQ, a leader in applying artificial intelligence to wearable sensor data, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their algorithm to continuously determine respiration rate in...

Ancora Heart, Inc., a company developing a novel therapy to address heart failure, announced the first patient was enrolled in the CorCinch EU study, a European multicenter clinical evaluation of the AccuCinch® Ventricular Repair System as a...

AtriCure, Inc., a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, announced that it has entered into a definitive agreement to acquire SentreHEART, Inc., a privately held developer of...

Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that HealthTech Arkansas, a healthcare accelerator and investment fund that connects early-stage healthcare...